In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. <br /><br />It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Tech on Drugs with Shai Shen-Orr
Claim This Podcastby CytoReason
Podcast Authority
Beta
Podcast Overview
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. <br /><br />It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Language
🇺🇲
Publishing Since
1/12/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Tech on Drugs with Shai Shen-Orr
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
December 15, 2025
Tech On Drugs - Se3Ep3 - Shai on Nvidia AI Podcast
In this special episode, we are sharing a conversation from the NVIDIA AI Podcast, hosted by Noah Kravitz, featuring our host Shai Shen-Orr.<br /><br />The discussion dives into CytoReason’s partnership with NVIDIA and how computational disease models turn massive biological data into actionable insights for faster, smarter drug development. Shai and Noah discuss:<br /><ul><li>Why biology is a deep data problem with too many features and too few samples</li><li>How agentic AI workflows help scientists keep up with exploding molecular and clinical data</li><li>Why CytoReason encourages teams to automate the routine to focus on what really matters</li><li>Why trust and interpretability are essential, with every prediction grounded in mechanism, not just statistics</li><li>And how computational disease models help pharma leaders decide what to develop, who to treat, and why</li></ul>Enjoy this special Tech on Drugs crossover episode!
August 8, 2025
Season 3 - Episode 2 - The Single Cell Revolution - Prof. Fabian Theis
What happens when two leading computational biologists swap code and models for a lively conversation?<br /><br />Prof. Fabian Theis — Director of the Computational Health Center at Helmholtz Munich, a pioneer in single-cell and AI-driven biomedical research, and a member of CytoReason’s Science Advisory Board — joins Prof. Shai Shen-Orr, Co-Founder & Chief Scientist at CytoReason, to talk about:<br /><ul><li>The single-cell revolution and how it’s reshaping the industry</li><li>The promise (and the hype) of foundational models</li><li>Why tomorrow’s R&D lab might be a “virtual biotech” — or even a one-person operation</li></ul>Tune in for a lively exchange full of insights and big ideas.<br /><br />
May 11, 2025
TOD - 2025_04_17 - Nir Hacohen
We’re kicking off Season 3 of Tech on Drugs with Prof. Nir Hacohen — Director of the Center for Cancer Research at MGH, founding director of the Broad Institute’s Cell Circuits Program, and a distinguished member of CytoReason's Science Advisory Board.<br /><br />Shai and Nir cover everything from the rise of antibodies and the promise (and pitfalls) of STING agonists, to the future of personalized cancer vaccines and a mysterious immune cell that appears only in patients with sepsis — a “cell that doesn’t exist” in healthy individuals.<br /><br />This is a candid look at how deep biology, smart computation, and persistence can reshape how we treat cancer.
13 total episodes available
Deep-dive analytics for Tech on Drugs with Shai Shen-Orr
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Tech on Drugs with Shai Shen-Orr?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.